Keap Calm, and Carry on Covalently
The DOI matches its Crossref record; 137 of the 140 references it cites were found in a registry or an index.
Abstract
The Nrf2-Keap1 system plays a major role in cellular defense against oxidative stress. Upon exposure to electrophiles, the cysteine-rich protein Keap1 is covalently modified, and it is this modification of Keap1 that allows the accumulation and subsequent nuclear translocation of Nrf2 where it induces the transcription of over 100 protective genes. This mechanism can be exploited in drug discovery approaches to diseases such as chronic kidney disease (CKD), chronic obstructive pulmonary disease (COPD), asthma, and neurodegenerative diseases like multiple sclerosis (MS) and Parkinson's, utilizing the modification of Keap1 by electrophiles, compounds that would not normally be considered useful in drug discovery programs. This Perspective discusses the development of potential therapies based on potent electrophiles, such as isothiocyanates and Michael acceptors, that, far from being associated with toxic events, can actually initiate a range of beneficial protective pathways.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additionally, some covalent inhibitors with reactive functional groups tend to be unattractive for drug discovery because of the poor pharmacokinetic values, especially high clearance [137].”
From The design and development of covalent protein-protein interaction inhibitors for cancer treatment (2020) · cites this paper as [137]
Citations
Cites
2 retracted
Malhotra, D., Thimmulappa, R., Navas-Acien, A., Sandford, A., Elliott, M., Singh, A., Chen, L., Zhuang, X., Hogg, J., Pare, P., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200803-380oc · Cited by 357
RetractedMukherjee, S., Gangopadhyay, H., & Das, D. K. (2008) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf0728146 · Cited by 124
RetractedItoh, K., Chiba, T., Takahashi, S., Ishii, T., Igarashi, K., Katoh, Y., Oyake, T., Hayashi, N., Satoh, K., Hatayama, I., et al. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6943 · Cited by 3,999
Cell Survival Responses to Environmental Stresses Via the Keap1-Nrf2-ARE Pathway
Kensler, T. W., Wakabayashi, N., & Biswal, S. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.46.120604.141046 · Cited by 3,630
BIOLOGY AND BIOCHEMISTRY OF GLUCOSINOLATES
Halkier, B. A., & Gershenzon, J. (2006) · Annual Review of Plant Biology · doi:10.1146/annurev.arplant.57.032905.105228 · Cited by 2,271
Dinkova-Kostova, A. T., Holtzclaw, W. D., Cole, R. N., Itoh, K., Wakabayashi, N., Katoh, Y., Yamamoto, M., & Talalay, P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172398899 · Cited by 1,947
The resurgence of covalent drugs
Singh, J., Petter, R. C., Baillie, T. A., & Whitty, A. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3410 · Cited by 1,873
Zhang, Y., Talalay, P., Cho, C. G., & Posner, G. H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.6.2399 · Cited by 1,682
Zhang, D. D., & Hannink, M. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.22.8137-8151.2003 · Cited by 1,480
Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution
Taguchi, K., Motohashi, H., & Yamamoto, M. (2011) · Genes to Cells · doi:10.1111/j.1365-2443.2010.01473.x · Cited by 1,478
Research works printed but not linked: 2
- Johansson M. H., 2012, Mini-Rev. Med. Chem., 12, 1330
- MacNee W., 2005, Curr. Drug Targets, 4, 627
Cited by
Items 101–195 of 195
DDQ-mediated regioselective C–S bond formation: efficient access to allylic sulfides
Li, C., Li, J., Tan, C., Wu, W., & Jiang, H. (2018) · Organic Chemistry Frontiers · doi:10.1039/c8qo00799c · Cited by 23
Scrutinizing the Therapeutic Potential of PROTACs in the Management of Alzheimer’s Disease
Bhatia, S., Singh, M., Singh, T., & Singh, V. (2023) · Neurochemical Research · doi:10.1007/s11064-022-03722-w · Cited by 22
Song, Z., Bai, F., Zhang, B., & Fang, J. (2020) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b06360 · Cited by 21
Varshney, V., & Garabadu, D. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06447-1 · Cited by 22
“Nuclear factor erythroid-derived like 2 (Nrf2) is a transcriptional factor that reduces cellular oxidative stress through induction of heme oxygenase-1 (HO-1), NAD(P) H: quinone reductase and glutathione S-transferase [19, 20].”
BackgroundLiu, X., Wang, Q., Zheng, J.-F., Chai, Z.-H., Dai, F., Jin, X., & Zhou, B. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.05.009 · Cited by 21
Construction of a novel quinoxaline as a new class of Nrf2 activator
Kandasamy, M., Mak, K., Devadoss, T., Veeraveedu, P. T., Sakirolla, R., Choudhury, H., & Pichika, M. R. (2019) · BMC Chemistry · doi:10.1186/s13065-019-0633-4 · Cited by 20
Waller, Z. A. E., Howell, L. A., Macdonald, C., O'Connell, M. A., & Searcey, M. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.03.117 · Cited by 20
Dilauro, G., Cicco, L., Perna, F. M., Vitale, P., & Capriati, V. (2017) · Comptes Rendus Chimie · doi:10.1016/j.crci.2017.01.008 · Cited by 19
Inactivation of protein tyrosine phosphatases by dietary isothiocyanates
Lewis, S. M., Li, Y., Catalano, M. J., Laciak, A. R., Singh, H., Seiner, D. R., Reilly, T. J., Tanner, J. J., & Gates, K. S. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.08.065 · Cited by 18
Yang, Z., Yan, Y., Li, A., Liao, J., Zhang, L., Yang, T., & Zhou, C. (2018) · New Journal of Chemistry · doi:10.1039/c8nj03461c · Cited by 18
Song, Z., Hou, Y., Bai, F., & Fang, J. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.104520 · Cited by 19
Modeling of ribonucleic acid–ligand interactions
Stefaniak, F., Chudyk, E. I., Bodkin, M. J., Dawson, W., & Bujnicki, J. M. (2015) · Wiley Interdisciplinary Reviews Computational Molecular Science · doi:10.1002/wcms.1226 · Cited by 20
“97 Also, a vast number of natural products can react with enzymes and thus may be used for the design of active-site-directed proteomic probes.”
BackgroundTowards the Iodine‐Catalyzed Regioselective Sulfenylation of Unsymmetrical Ketones
Devi, N., Rahaman, R., Sarma, K., Khan, T., & Barman, P. (2017) · European Journal of Organic Chemistry · doi:10.1002/ejoc.201601562 · Cited by 15
Liu, S., Wang, L., Ma, Z., Zeng, X., & Xu, B. (2020) · Organic Chemistry Frontiers · doi:10.1039/d0qo01052a · Cited by 15
Pinto, A., Ali, Z. E., Moniot, S., Tamborini, L., Steegborn, C., Foresti, R., & Micheli, C. D. (2018) · ChemistryOpen · doi:10.1002/open.201800185 · Cited by 15
Mak, K., Zhang, S., Epemolu, O., Dinkova‐Kostova, A. T., Wells, G., Gazaryan, I. G., Sakirolla, R., Zulkefeli, M., & Pichika, M. R. (2022) · ChemistryOpen · doi:10.1002/open.202200181 · Cited by 15
Qi, Z., Tong, Y., Luo, H., Chen, M., Zhou, N., & Chen, L. (2023) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2023.106350 · Cited by 13
Bronson, J. J., Black, A., Dhar, T. G. M., Ellsworth, B. A., & Merritt, J. R. (2014) · Annual reports in medicinal chemistry · doi:10.1016/b978-0-12-800167-7.00027-4 · Cited by 16
Potent haloperidol derivatives covalently binding to the dopamine D2 receptor
Schwalbe, T., Kaindl, J. M., Hübner, H., & Gmeiner, P. (2017) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.06.034 · Cited by 15
Du, Y., Zheng, Y.-L., Ji, Y., Dai, F., Hu, Y.-J., & Zhou, B. (2018) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.8b02442 · Cited by 12
Targeting Thioredoxin Reductase by Ibrutinib Promotes Apoptosis of SMMC-7721 Cells
Han, X., Zhang, J., Shi, D., Wu, Y., Liu, R., Liu, T., Xu, J., Yao, X., & Fang, J. (2019) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.118.254862 · Cited by 13
“It has been reported that inhibition of the Trx system can lead to arrest of cell cycle and migration (Boronat et al., 2017; Xie et al., 2017), which was also obtained in our experimental results (Fig.”
ResultHispolon alleviates oxidative damage by stimulating the Nrf2 signaling pathway in PC12 cells
Peng, S., Hou, Y., & Chen, Z. (2022) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2022.109303 · Cited by 11
Li, Y., Zhang, J., She, M., Liu, L., Yang, Z., Liu, P., Zhang, S., & Li, J. (2023) · Green Chemistry · doi:10.1039/d3gc00664f · Cited by 11
Precious Cargo: The Role of Polymeric Nanoparticles in the Delivery of Covalent Drugs
Weissberger, D., Stenzel, M. H., & Hunter, L. (2024) · Molecules · doi:10.3390/molecules29204949 · Cited by 12
“Covalent drugs contain a reactive functional group, or “warhead”, that can form a strong chemical bond with the biological target (Figure 1) [1].”
BackgroundLin, T.-X., Cai, X., Wang, Y., Xu, J., Xiao, J.-H., Huang, H., Li, S., Liu, K., Chen, J., Li, L., et al. (2025) · Antioxidants · doi:10.3390/antiox14030248 · Cited by 12
In Situ Observation of Thiol Michael Addition to a Reversible Covalent Drug in a Crystalline Sponge
Duplan, V., Hoshino, M., Li, W., Honda, T., & Fujita, M. (2016) · Angewandte Chemie · doi:10.1002/ange.201509801 · Cited by 10
Structural basis of Nrf2 activation by flavonolignans from silymarin
Bello, M. (2022) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2022.108393 · Cited by 11
Luo, Y.-H., Cheng, H., Tsai, F., Tsou, T., Lin, S., & Lin, P. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s268203 · Cited by 11
Electrophilic Triterpenoid Enones: A Comparative Thiol-Trapping and Bioactivity Study
Prete, D. D., Taglialatela‐Scafati, O., Minassi, A., Sirignano, C., Cruz, C., Bellido, M. L., Muñóz, E., & Appendino, G. (2017) · Journal of Natural Products · doi:10.1021/acs.jnatprod.7b00271 · Cited by 9
Boehm, J. C., Davis, R., Murar, C. E., Li, T., McCleland, B. W., Dong, S., Yan, H., Kerns, J. K., Moody, C. J., Wilson, A. J., et al. (2018) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2018.12.026 · Cited by 10
Self-citationLin, H., Qiao, Y., Yang, H., Li, Q., Chen, Y., Qu, W., Liu, W., Feng, F., & Sun, H. (2019) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2019.126853 · Cited by 8
Development of Keap1-interactive small molecules that regulate Nrf2 transcriptional activity
Georgakopoulos, N., Gatliff, J., & Wells, G. (2016) · Current Opinion in Toxicology · doi:10.1016/j.cotox.2016.08.002 · Cited by 8
Yang, J., Gu, Y. H., Guo, Y., Lv, X., Liu, B., Liu, Y., & Rong, L. (2023) · ChemistrySelect · doi:10.1002/slct.202300307 · Cited by 7
Patenting perspective on Keap1 inhibitors (2019–2024)
Luo, Y., Yang, W., Zhang, Y., Jiang, S., Zhu, J., Li, X., You, Q., & Lu, M. (2025) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2025.2462844 · Cited by 6
“A plethora of electrophilic compounds have been identified that mimic this Keap1 inhibition mode, preventing the ubiquitination of Keap1 substrates, particularly Nrf2, and exerting their activation effects [63].”
Yao, J., Liu, Y., Lin, H., Shao, C., Jin, X., Peng, T., & Liu, Y. (2025) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2025.111325 · Cited by 7
“The covalent modification of Keap1 can promote the release and activation of Nrf2 (Wilson et al., 2013), and previous studies have confirmed the neuroprotective ability and the potential to activate Nrf2 of CA.”
Hemin‐Promoted Direct C−H Thiolation in the Synthesis of Diaryl Sulfides
Li, B., Wang, J., Tu, G., Ju, G., Zhou, K., & Zhao, Y. (2023) · European Journal of Organic Chemistry · doi:10.1002/ejoc.202201458 · Cited by 6
Pérez, H. L., Junnotula, V., Knecht, D. M., Nie, H., Sanchez, Y., Boehm, J. C., Booth-Genthe, C. L., Yan, H., Davis, R., & Callahan, J. F. (2014) · The Analyst · doi:10.1039/c3an02216a · Cited by 6
Self-citationWang, Q., Dong, L., Liu, X., Dai, F., Jin, X., & Zhou, B. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.12.011 · Cited by 5
Synthesis of P-, S-, Si-, B-, and Se-Heterocycles via Ring-Closing Metathesis
Jun, J. H., Javed, S., Ndi, C. N., & Hanson, P. R. (2015) · Topics in heterocyclic chemistry · doi:10.1007/7081_2015_162 · Cited by 5
The paradoxical influence of the pKa on the reactivity of thiols and its biological relevance
Bianchi, D. H. A. (2016) · MaRBLe · doi:10.26481/marble.2014.v2.316 · Cited by 5
“Target genes of Nrf2 are involved in GSH biosynthesis [10, 13],”
BackgroundOrtalli, M., Morselli, S., Gritti, T., Suprani, L. A., Castelli, G., Bruno, F., Oliveri, E., Fabrizio, V., Cannarozzi, A., Perrone, G. C. M., et al. (2026) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2026.109713 · Cited by 3
George, N., Akhtar, M. J., Balushi, K. A. A., Safi, S. Z., Azmi, S. N. H., & Khan, S. A. (2023) · Medicinal Chemistry Research · doi:10.1007/s00044-023-03026-w · Cited by 4
“Keap-1 is a well-known substrate for Cullin 3(Cul3)/ring-box1 (Rbx1) which is an E3 ubiquitin ligase and forms a complex with the substrate [42].”
BackgroundQin, H., Zhang, Y., & Huang, P. C. (2023) · ChemistrySelect · doi:10.1002/slct.202300966 · Cited by 3
Tong, J.-B., Wang, J., Luo, D., Xiao, X., Xu, H., Bian, S., & Zhang, X. (2022) · Structural Chemistry · doi:10.1007/s11224-022-01909-z · Cited by 3
“It is clear known that pharmacological activation of Nrf2 is a relatively reliable method for the treatment of oxidative stress and inflammation-related neurodegenerative diseases [8].”
MethodFuertes, P., García‐Valverde, M., Pascual, R., Rodríguez, T., Rojo, J., García‐Calvo, J., Calvo, P., Cuevas, J. V., García‐Herbosa, G., & Torroba, T. (2014) · The Journal of Organic Chemistry · doi:10.1021/jo501473z · Cited by 3
Selective Cytotoxicity of Dams in Derivatives in Breast Cancer Cells
Lozano, M., Lozano, M., Soria, W., Soria, W., Almanza, G. R., Manner, S., Oredsson, S., Villagomez, R., & Sterner, O. (2019) · Journal of Advanced Pharmaceutical Science and Technology · doi:10.14302/issn.2328-0182.japst-19-2759 · Cited by 3
“In general, electrophilic compounds are considered potentially toxic and have been rejected by the pharmaceutical industry in their search for novel drug candidates.(7,8) However, 39 electrophilic drugs, mainly used in oncological therapies, have been approved by the US Food and Drug Administration.”
BackgroundShin, S. G., Oh, H.-W., Kim, B. C., Ok, J., Lee, S. I., Youn, S. P., Bae, H. H., Park, J. Y., Han, J. W., & Lee, C. H. (2024) · Synthetic Communications · doi:10.1080/00397911.2024.2441336 · Cited by 2
Cairang, N., Wu, Y., Zhi, S., Tang, J., Tie, X., Zhan, D., Lu, G., Shi, Y., & Zhao, Q. (2025) · RSC Advances · doi:10.1039/d4ra06512c · Cited by 3
Silva, A., Silva, S., Rodrigues, B., Simões, G., Dinis, I., Freitas, M., Resende, R., Bicker, J., Fortuna, A. C., Silva, M. M., et al. (2025) · Oxidative Medicine and Cellular Longevity · doi:10.1155/omcl/7695056 · Cited by 2
“Most pharmacological NRF2 activators are electrophilic molecules that covalently modify cysteine residues present in the thiol-rich KEAP1 protein by oxidation or alkylation [9 – 11].”
Muhammad, E. F., Kumar, A., Wahab, H. A., & Zhang, K. Y. J. (2021) · Molecular Informatics · doi:10.1002/minf.202100020 · Cited by 3
Epigenetic Regulators of NRF2: Exploring Therapeutic Opportunities in Cancer
Bhattacharjee, S. (2021) · Handbook of Oxidative Stress in Cancer: Therapeutic Aspects · doi:10.1007/978-981-16-1247-3_73-1 · Cited by 2
Tang, J., Tie, X., Zhi, S., Wang, Z., Zhao, Q., Qu, Z., Lu, G., Li, Q., Wu, Y., & Shi, Y. (2024) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2024.107741 · Cited by 4
Dai, H., Jiao, Q., Liu, T., You, Q., & Jiang, Z. (2017) · Molecules · doi:10.3390/molecules22091541 · Cited by 2
“The most successful Nrf2/ARE inducers are traditional electrophilic Nrf2 activators, which may mimic this endogenous process of Nrf2 by Keap1 thiols modification [12,13].”
BackgroundLiu, Y., Yuan, X., Su, K., Tian, Y., & Chen, B. (2018) · European Journal of Organic Chemistry · doi:10.1002/ejoc.201801806 · Cited by 2
Gibson, T. (2016) · Wiley-VCH eBooks · doi:10.1002/9783527693931.ch15 · Cited by 1
Mak, K., Shiming, Z., Epemolu, O., Dinkova‐Kostova, A. T., Wells, G., Gazaryan, I. G., Sakirolla, R., Zulkefeli, M., & Pichika, M. R. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4097876 · Cited by 1
Park, B. K., & Smith, D. A. (2016) · Wiley eBooks · doi:10.1002/9781118949689.ch14
Multiobjective Optimization of Biological and Physical Properties in Drug Discovery
Gleeson, M. P., & Montanari, D. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.12315-7 · Cited by 1
Maity, P., Sarkar, P., & Mukhopadhyay, C. (2021) · Tetrahedron Letters · doi:10.1016/j.tetlet.2021.153479
Epigenetic Regulators of NRF2: Exploring Therapeutic Opportunities in Cancer
Bhattacharjee, S. (2022) · Handbook of Oxidative Stress in Cancer: Therapeutic Aspects · doi:10.1007/978-981-16-5422-0_73
Kim, T., Kim, H. S., Bang, Y., Kwon, Y., Kim, J., Choi, H. J., & Suh, Y. (2024) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2024.107109 · Cited by 1
Multiobjective optimization of biological and physical properties in drug discovery
Gleeson, M. P., & Montanari, D. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-29808-0.00014-5
Zhang, Y., Lin, D., Yao, X., Dai, F., Wang, Q., & Zhou, B. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2025.12.007
A Hetero-multivalent Covalent Strategy for Enhanced Pulmonary Fibrosis TherapyPreprint
Ge, G., Zhu, G., Deng, Y., Wu, H., Zhang, H., Zhu, G., Zeng, H., Li, N., Wang, L., Fan, Y., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-9244913/v1
Shi, Y., Tie, X., Tao, G., Jia, Y., Huang, Q., Lu, G., & Wu, Y. (2026) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2026.118716 · Cited by 1
Protein–Protein Interactions: Emerging Drug Targets
Silverman, R. B., Xue, F., & Juncosa, J. I. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-15862-9.00010-2
Callahan, J. F., Davies, T. G., Bantscheff, M., Bédard, S., Boehm, J. D., Booth-Genthe, C. L., Concha, N. O., Copley, R. C. B., Davis, A., Davis, R., et al. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6c01820
Self-citationBindingDB Entry 50010808: Medicinal Chemistry of Inhibiting RING-Type E3 Ubiquitin Ligases.
BindingDB (2021) · UC San Diego · doi:10.7270/q2qn6bbk
BindingDB (2023) · UC San Diego · doi:10.7270/q2q52trd
BindingDB (2020) · UC San Diego · doi:10.7270/q2vx0k32
BindingDB Entry 50044153: Oxidative stress in Alzheimer's disease: are we connecting the dots?
BindingDB (2015) · UC San Diego · doi:10.7270/q2pk0hpv
BindingDB Entry 50006254: Non-electrophilic modulators of the canonical Keap1/Nrf2 pathway.
BindingDB (2020) · UC San Diego · doi:10.7270/q20v8gsc
BindingDB (2021) · UC San Diego · doi:10.7270/q2pk0kkb
BindingDB (2021) · UC San Diego · doi:10.7270/q2zk5m5r
BindingDB Entry 50018333: Recent progress in Keap1-Nrf2 protein-protein interaction inhibitors.
BindingDB (2024) · UC San Diego · doi:10.7270/q2b85dbt
BindingDB (2020) · UC San Diego · doi:10.7270/q2222x70
Metadata
- Authors
- Wilson, A. J., Kerns, J. K., Callahan, J. F., & Moody, C. J.
- Affiliations
- University of Nottingham (GB)
- GlaxoSmithKline (United States) (US)
- Corresponding author
- Moody, Christopher J.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2013-07-25
- Volume
- 56
- Issue
- 19
- Pages
- 7463-7476
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2081058334
- Cited by
- 171
- References
- 140
- Citations by year
- 2026: 5 · 2025: 10 · 2024: 7 · 2023: 10 · 2022: 11 · 2021: 9 · 2020: 17 · 2019: 14 · 2018: 18 · 2017: 14 · 2016: 25 · 2015: 19 · 2014: 11 · 2013: 1
- FWCI
- 9.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Medicinal Chemistry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics, phytochemicals, and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glutathione Transferases and Polymorphisms
- Keywords
- Nrf2/Keap1 pathway, electrophiles, oxidative stress, isothiocyanates, Michael acceptors, Nrf2 nuclear translocation, chronic kidney disease, chronic obstructive pulmonary disease, asthma, multiple sclerosis, Parkinson's disease, neurodegenerative diseases
- MeSH terms
- Kelch-Like ECH-Associated Protein 1, Animals, Cell Nucleus, Esters, Humans, Ketones, Protein Binding, Protein Conformation, Sulfoxides, Isothiocyanates, Active Transport, Cell Nucleus, Intracellular Signaling Peptides and Proteins, NF-E2-Related Factor 2, Drug Discovery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.